Clinician Scientist and Consultant Haematologist, University of Cambridge
Ingo Ringshausen studied medicine at the Johannes Gutenberg University in Mainz/ Germany and London/ Canada. After his graduation in 1999 he started his medical training in Internal Medicine and Haematology/ Oncology at the Technical University in Munich. Between 2003 and 2006 he joined the group of Gerard Evan at UCSF on a postdoctoral fellowship. After his board certification in 2010 he became a Consultant in the Department of Haematology/ Oncology in Munich and subsequently an independent group leader.
In 2014 he joined the Department of Haematology in Cambridge and is now appointed as Consultant Haematologist at Addenbrooke’s hospital and a Principal Investigator at the CSCI.
Cancer treatment: study finds targeting nearby 'normal' cells could improve survival rates
Jan 18, 2020 11:55 am UTC| Health
Cancer of the immune system, called lymphoma or leukaemia, generally affects the entire bodys bone marrow and lymph nodes. Because these types of cancers are so widespread, surgery isnt useful, so patients are usually...
The Alberta government is interfering in public sector bargaining on an unprecedented scale
Putin’s Russia: first arrests under new anti-LGBT laws mark new era of repression
Canada needs a national strategy for homeless refugee claimants